Mine otse sisu juurde
HPB-ALL
Kude
Peripheral blood
Haigus
Precursor T-cell acute lymphoblastic leukemia
Metastaaside asukoht
Peripheral blood (systemic T-ALL)
Sünonüümid
HPB/ALL, HPBALL, FCCH1018

Dokumendid

HPB-ALL

Cell line · Toote number 302895

HPB-ALL on inimese T-rakkude ägeda lümfoblastilise leukeemia (T-ALL) eellaste rakuliin, mis on saadud 14-aastase jaapani poisi perifeersest verest...

€430.00ilma käibemaksu ja saatmiskuludeta

Kohandamine / Soovitused

Laos
Lot
Soovitatav (värskeim partii)
  • CoA
1

01Üldine teave

Kirjeldus

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Kude
Peripheral blood
Haigus
Precursor T-cell acute lymphoblastic leukemia
Metastaaside asukoht
Peripheral blood (systemic T-ALL)
Rakendused
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sünonüümid
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Klassifikatsioon

Organism
Inimene
Sugu
Mees
Kasvuvõime
Vedrustus
Bioloogilise ohutuse tase
1

03Omadused

Morfoloogia
Lymphoblast-like
Rakutüüp
T-cell
Kahekordistumisaeg
~50 hours

04Tunnused

Viide
HPB-ALL (Cytion catalog number 302895)
NCBI maksukood
9606
Cellosaurus
CVCL_1820

05Avaldumine ja vastuvõtlikkus

Mutatsiooniprofiil
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Käsitlemine ja kasvatamine

Kasvatuskeskkond
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Toidulisandid
Supplement the medium with 10% FBS
Dissotsiatsioonireaktiiv
dilution
Kultuuri edasikasvatamine
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Jagamissuhe
1 : 10 split
Külvitihedus
3-5*10^5/ml
Vedeliku vahetus
Subculture : 2 times/week
Sulatamine ja kasvatamine
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Kvaliteedikontroll ja krüokonserveerimine

Külmutuskeskkond
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Säilitamistingimused

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Tarne- ja kohaletoimetamistingimused

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Annetaja

Doonori vanus
14 years
Etniline kuuluvus
Japanese

10Toote üksikasjad

Koostis tabel